MedPath

Ipecac

Generic Name
Ipecac
Drug Type
Small Molecule
CAS Number
8012-96-2
Unique Ingredient Identifier
62I3C8233L

Overview

Ipecac is obtained from the plant Cephaelis ipecacuanha and contains a number of emetic alkaloids including emetine and cephaeline. Ipecac was approved by Health Canada as an OTC but all those products are now discontinued. The FDA does not have currently any approved product containing ipecac, however, ipecac as an ingredient is accepted to be sold over the counter in packages of 1 fluid ounce (30 ml) for the emergency use to cause vomiting in poisoning.

Indication

Ipecac is indicated as an emetic agent for the induction of vomiting in poisoning victims who ingested systemic poison in order to prevent absorption of the chemicals through the gastrointestinal tract. In low doses, ipecac was also used as an expectorant. Reports have suggested that ipecac was vastly used in patients with eating disorders to produce vomiting.

Associated Conditions

  • Allergic cough
  • Bronchitis
  • Cough
  • Cough caused by Common Cold
  • Rhinorrhoea
  • Sore Throat

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Newton Laboratories, Inc.
55714-2465
ORAL
15 [hp_X] in 1 mL
8/20/2025
Genexa Inc.
69676-0073
ORAL
12 [hp_X] in 1 1
4/16/2025
Deseret Biologicals, Inc.
43742-1324
ORAL
6 [hp_C] in 1 mL
5/27/2025
Schwabe North America, Inc
53499-0349
ORAL
3 [hp_X] in 912 mg
7/31/2025
Newton Laboratories, Inc.
55714-2466
ORAL
15 [hp_X] in 1 g
8/20/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
AFRICAN SEA-COCONUT COUGH MIXTURE
SIN03619P
SOLUTION
0.112ml /5ml
7/15/1989

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
FUTALO COUGH SYRUP
N/A
N/A
N/A
8/21/1989
EPHEMO COUGH SYRUP
N/A
N/A
N/A
1/30/1985
CORYLIN SYRUP
N/A
N/A
N/A
8/30/1984
UNI-COPHEDENE SYRUP WITHOUT HONEY
N/A
N/A
N/A
7/14/1998

TGA Drug Approvals

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
IPECAC SYRUP
d.c. labs limited
00093858
Syrup - Oral
140 MG / 100 ML
12/31/1964
HOMEO-FORM R - GRANULES
homeocan inc.
02151413
Tablet - Oral
9 X
12/31/1995
DROSETUX
dolisos laboratoires s.a.
02242696
Syrup - Oral
3 CH / 250 ML
10/6/2000
IPECAC PWR 4X
koegler laboratories inc.
00858439
Powder - Oral
4 X / X
12/31/1989
HEEL 025 TAB
01969307
Tablet - Oral
4 D / TAB
12/31/1992
POUR IT ON THICK
kootenay born botanicals
02232067
Syrup - Oral
12 X
5/25/1998
NV NIX
terra botanica products ltd.
02233354
Liquid - Oral
30 X
5/25/1998
IPECACUANHA GLOBULE 6CH-1000CH
thompson's homeopathic supplies ltd.
01919849
Tablet - Oral
6 CH / CH
12/31/1991
IPECA GRAN (3X-30X)
laboratoires holis inc.
01952455
Tablet - Oral
3 X / TAB
12/31/1984
IPECA GOUTTE 2CH - 30CH
boiron laboratoires
00678643
Drops - Oral
2 CH / CH
12/31/1987

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.